General Hospital Psychiatry
Volume 30, Issue 1 , Pages 49-54 , January 2008

Psychiatric disorders in hypertrophic cardiomyopathy

  • John F. Morgan, M.D., M.R.C.Psych.

      Affiliations

    • Department of Psychiatry, Yorkshire Centre for Eating Disorders, Seacroft Hospital, LS14 6UH LEEDS, UK
    • Corresponding Author InformationCorresponding author. Tel.: +44 181 725 5565; fax: +44 181 725 3350.
    • ,
  • Ann C. O'Donoghue, R.N.

      Affiliations

    • The Heart Hospital, University College London NHS Foundation Trust, 16-18 Westmoreland Street, W1G 8PH London, UK
    • ,
  • William J. McKenna, M.D. F.R.C.P.

      Affiliations

    • The Heart Hospital, University College London NHS Foundation Trust, 16-18 Westmoreland Street, W1G 8PH London, UK
    • ,
  • Martin M. Schmidt, M.R.C.Psych.

      Affiliations

    • Department of Psychiatry, St. George’s University of London, Cranmer Terrace, SW17 0RE London, UK

Received 25 July 2007 ,Accepted 26 September 2007.

References 

  1. Maron BJ, Gardin JM, Flack JM, et al. Prevalence of hypertrophic cardiomyopathy in a general population of young adults. Circulation. 1995;92:785–789
  2. Cox S, O'Donoghue AC, McKenna WJ, Steptoe A. Health related quality of life and psychological well-being in patients with hypertrophic cardiomyopathy. Heart. 1997;78:182–187
  3. Freedland KE, Lustman PJ, Carney RM, Hong BA. Underdiagnosis of depression in patients with coronary artery disease. Int J Psychiatry Med. 1992;22:221–229
  4. Carney RM, Rich MW, TeVelde A, et al. Major depressive disorder in coronary artery disease. Am J Cardiol. 1987;60:1273–1275
  5. Veith RC, Raskind MA, Caldwell JH, et al. Cardiovascular effects of tricyclic antidepressants in depressed patients with chronic heart disease. N Engl J Med. 1982;306:954–959
  6. Maron BJ, Bonow RO, Cannon RO, Leon MB, Epstein SE. Hypertrophic cardiomyopathy. Interrelations of clinical manifestations, pathophysiology, and therapy (1). N Engl J Med. 1987;316:780–789
  7. Maron BJ, Bonow RO, Cannon RO, Leon MB, Epstein SE. Hypertrophic cardiomyopathy. Interrelations of clinical manifestations, pathophysiology, and therapy (2). N Engl J Med. 1987;316:844–852
  8. Spirito P, Seidman CE, McKenna WJ, Maron BJ. The management of hypertrophic cardiomyopathy. N Engl J Med. 1997;336(11):755–785
  9. Herrmann C. International experiences with the hospital anxiety and depression scale — a review of validation data and clinical results. J Psychosom Res. 1997;42:17–41
  10. Zigmond AS, Snaith RP. The Hospital Anxiety and Depression Scale. Acta Psychiatr Scand. 1983;67:361–370
  11. Cooper PJ, Osborn M, Gath D, Feggetter G. Evaluation of a modified self-report measure of social adjustment. Br J Psychiatry. 1982;141:68–75
  12. Spitzer RL, Williams JBW, Gibbon M, First MB. User's guide for the Structured Clinical Interview for DSM-III-R. Washington (DC): American Psychiatric Press Inc; 1990;
  13. Robins LN, Helzer JE, Weissman MM, et al. Lifetime prevalences of specific psychiatric disorders in three sites. Arch Gen Psychiatry. 1984;41:949–958
  14. Wood P. Da Costa's syndrome (or effort syndrome). BMJ. 1941;i:767–851
  15. Mayou R. Prediction of emotional and social outcome after a heart attack. J Psychosom Res. 1984;28:17–26
  16. Mayou R, Bryant B. Quality of life after coronary artery surgery. Q J Med. 1987;62:239–248
  17. Jones DA, West RR. Psychological rehabilitation after myocardial infarction: multicentre randomised trial. BMJ. 1996;313:1517–1521
  18. Mancini D, LeJemtel T, Aaronson K. Peak VO (2): a simple yet enduring standard. Circulation. 2000;101:1080–1082

PII: S0163-8343(07)00188-0

doi: 10.1016/j.genhosppsych.2007.09.005

General Hospital Psychiatry
Volume 30, Issue 1 , Pages 49-54 , January 2008

Article Tools